Showing results (31-40 of 100) with videos related to
Sort By:
Pageof 10
Thyroid : Official Journal of the American Thyroid Association|November 2, 2023
Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid CancersDavid Toro-Tobon, John C Morris, Crystal Hilger, et al.Cancer Treatment Reviews|April 29, 2018
Management of treatment-related toxicities in advanced medullary thyroid cancerMarcia S Brose, Keith C Bible, Laura Q M Chow, et al.Endocrine-Related Cancer|August 23, 2008
Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancerMabel Ryder, Ronald A Ghossein, Julio C M Ricarte-Filho, et al.Endocrine-Related Cancer|July 6, 2013
Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cellsMatti L Gild, Iñigo Landa, Mabel Ryder, et al.Melanoma Research|June 17, 2016
A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapyLisa Kottschade, Adam Brys, Tobias Peikert, et al.Advances in Radiation Oncology|March 21, 2018
External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytomaWilliam Breen, Irina Bancos, William F Young, et al.Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 31, 2021
Immune checkpoint inhibitor-induced hypophysitis: lessons learnt from a large cancer cohortAnupam Kotwal, Samuel G Rouleau, Surendra Dasari, et al.The Journal of Clinical Endocrinology and Metabolism|March 18, 2014
Development and characterization of a differentiated thyroid cancer cell line resistant to VEGFR-targeted kinase inhibitorsCrescent R Isham, Brian C Netzel, Ayoko R Bossou, et al.The Journal of Clinical Endocrinology and Metabolism|October 14, 2017
Survival in Response to Multimodal Therapy in Anaplastic Thyroid CancerNaiyarat Prasongsook, Aditi Kumar, Ashish V Chintakuntlawar, et al.Pageof 10